Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to 0.17.

  • Collegium Pharmaceutical's Equity Ratio rose 1933.01% to 0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year increase of 1933.01%. This contributed to the annual value of 0.14 for FY2024, which is 1952.54% down from last year.
  • As of Q3 2025, Collegium Pharmaceutical's Equity Ratio stood at 0.17, which was up 1933.01% from 0.15 recorded in Q2 2025.
  • Collegium Pharmaceutical's Equity Ratio's 5-year high stood at 0.35 during Q2 2021, with a 5-year trough of 0.14 in Q4 2024.
  • Over the past 5 years, Collegium Pharmaceutical's median Equity Ratio value was 0.17 (recorded in 2023), while the average stood at 0.19.
  • In the last 5 years, Collegium Pharmaceutical's Equity Ratio soared by 4724.43% in 2021 and then plummeted by 5525.47% in 2022.
  • Over the past 5 years, Collegium Pharmaceutical's Equity Ratio (Quarter) stood at 0.29 in 2021, then plummeted by 43.4% to 0.17 in 2022, then rose by 3.01% to 0.17 in 2023, then dropped by 19.53% to 0.14 in 2024, then rose by 24.29% to 0.17 in 2025.
  • Its Equity Ratio stands at 0.17 for Q3 2025, versus 0.15 for Q2 2025 and 0.14 for Q1 2025.